Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma

BACKGROUND: Bone marrow infiltration of lymphoma cells is a candidate risk factor for infusion-related reactions (IRRs) in patients with CD20-positive B-cell non-Hodgkin lymphoma (B-NHL). However, despite with the lack of sufficient data, the effect of bone marrow infiltration of B-NHL cells on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohata, Shinya, Takenaka, Kei, Sugiyama, Daisuke, Sugimoto, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856829/
https://www.ncbi.nlm.nih.gov/pubmed/35189630
http://dx.doi.org/10.1155/2022/3688727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856829/
https://www.ncbi.nlm.nih.gov/pubmed/35189630
http://dx.doi.org/10.1155/2022/3688727

Ejemplares similares